Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

45.05
+2.074.82%
Pre-market: 45.170.1160+0.26%08:10 EDT
Volume:20.52M
Turnover:918.07M
Market Cap:65.29B
PE:18.25
High:45.15
Open:44.00
Low:43.85
Close:42.98
52wk High:105.65
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.91
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.62
PE(LYR):23.22

Loading ...

Movement Alert|Boston Scientific Rises 3.72% in Regular Trading, Trading at $48.685

Market Focus
·
Aug 03

Boston Scientific FY26 Q2 Net Income Rises 13.8% to 907 Million; Net Sales Climb 7.5% to 5.44 Billion

Reuters
·
Aug 03

Why Boston Scientific (BSX) Is Up 5.6% After Mixed Q2, Recall News And Guidance Update

Simply Wall St.
·
Aug 02

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 01

Movement Alert|Boston Scientific Falls 3.13% in Regular Trading, Argus Downgrades Rating to Hold Extending Post-Earnings Selling Pressure

Market Focus
·
Jul 31

Argus Downgrades Boston Scientific to Hold From Buy

MT Newswires Live
·
Jul 31

Boston Scientific Cut to Hold from Buy by Argus Research

Dow Jones
·
Jul 31

Boston Scientific Corp : Argus Research Cuts to Hold from Buy

THOMSON REUTERS
·
Jul 31

Boston Scientific (BSX) Stock Ignores Margin Strength As Growth Outlook Softens

Simply Wall St.
·
Jul 31

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Penumbra Q2 FY26 Net Income Falls to 34.81 Million; Revenue Rises 14.9% to 390 Million

Reuters
·
Jul 31

Penumbra Q2 Revenue Slightly Beats Estimates, Helped by Product Segment Increase

Reuters
·
Jul 31

Cerus Q2 Adjusted Ebitda Misses Estimates, Raises 2026 Outlook

Reuters
·
Jul 31

Penumbra - Will not Provide Full Year 2026 Guidance or Host Conference Call Due to Pending Acquisition

THOMSON REUTERS
·
Jul 31

Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says

MT Newswires Live
·
Jul 31

Boston Scientific Lowered Full-Year Guidance on Headwinds in Electrophysiology, Watchman Portfolios, RBC Says

MT Newswires Live
·
Jul 30

Movement Alert|Boston Scientific Falls 3.06% in Regular Trading, Multiple Banks Cut Price Targets Post-Earnings on Watchman Weakness

Market Focus
·
Jul 30

UBS Adjusts Boston Scientific Price Target to $67 From $74, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Deutsche Bank Adjusts Boston Scientific PT to $60 From $75, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Baxter Q2 Revenue Rises 5%, Beats Analyst Estimates

Reuters
·
Jul 30